Medicom Oncology Clinical Pearls Podcasts
The standard of care for patients receiving lenalidomide or thalidomide who are at high risk for VTE
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:03:36
- Mas informaciones
Informações:
Sinopsis
Dr. Ruben Niesvizky discusses clinical approaches to managing the risk of developing VTE in myeloma patients receiving immunomodulating agents such as lenalidomide or thalidomide.
